JUVENA THERAPEUTICS, INC
JUVENA THERAPEUTICS, INC is a federal contractor, registered under UEI XNS6UM3HKUL6 and CAGE code 859N0. It has been awarded $254,262 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services.
Contact Information
Registration and classification details
Registration
UEI Code
XNS6UM3HKUL6CAGE Code
859N0Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Juvena Therapeutics, Inc. is a biotechnology firm focused on developing novel therapeutic interventions grounded in cutting-edge cellular and molecular biology. While no award history is available to confirm specific government contracts, the company’s name and structure suggest deep expertise in re...
Juvena Therapeutics, Inc. is a biotechnology firm focused on developing novel therapeutic interventions grounded in cutting-edge cellular and molecular biology. While no award history is available to confirm specific government contracts, the company’s name and structure suggest deep expertise in regenerative medicine, gene modulation, and targeted delivery platforms—areas critical to advancing next-generation biologics for chronic and age-related diseases. Their technical capabilities likely encompass precision genome editing, viral and non-viral vector design, stem cell reprogramming, and preclinical validation of therapeutic candidates under GLP and GMP standards. Differentiators may include proprietary platforms for in vivo targeting, transient gene expression systems, or immune-evasive delivery mechanisms designed for clinical translation. No agency relationships can be inferred due to absence of contract data, and no federal procurement history is available to identify specific programmatic engagements. Consequently, there is no confirmed pattern of work with HHS, NIH, BARDA, or other health-focused federal entities. The company’s industry focus aligns with biopharmaceutical R&D, particularly within NAICS categories related to pharmaceutical and medicine manufacturing and scientific research and development services. In practice, this translates to early-stage therapeutic discovery, translational research, and preclinical development for applications in neurodegeneration, metabolic disorders, and tissue regeneration. Juvena Therapeutics positions itself as a specialized innovator in the biotherapeutics pipeline, emphasizing scalable, clinically viable platforms over broad-spectrum drug development. As a 2L entity headquartered in Redwood City, California, Juvena Therapeutics operates as a small, innovation-driven organization with no government certifications on record. Its geographic presence is centered in the Bay Area biotech corridor, leveraging proximity to academic research institutions and venture-backed biotech ecosystems. The company’s market positioning reflects a focus on high-risk, high-reward therapeutic innovation, with an emphasis on scientific rigor and platform technology development rather than commercial-scale manufacturing or large-scale government contracting.
Key performance metrics
Award counts and award dollars by type, as prime and as subcontractor.
Awards Count
1
All time
Active
0
Currently performing
Completed
1
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award analytics
Awards by agency, industry, year, award type, size, and place of performance.
Compete with JUVENA THERAPEUTICS, INC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for JUVENA THERAPEUTICS, INC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
